These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The role of germline mutations in the BRCA1/2 and mismatch repair genes in men ascertained for early-onset and/or familial prostate cancer. Maia S; Cardoso M; Paulo P; Pinheiro M; Pinto P; Santos C; Pinto C; Peixoto A; Henrique R; Teixeira MR Fam Cancer; 2016 Jan; 15(1):111-21. PubMed ID: 26289772 [TBL] [Abstract][Full Text] [Related]
24. First evidence for the contribution of the genetic variations of BRCA1-interacting protein 1 (BRIP1) to the genetic susceptibility of cervical cancer. Ma XD; Cai GQ; Zou W; Huang YH; Zhang JR; Wang DT; Chen BL Gene; 2013 Jul; 524(2):208-13. PubMed ID: 23644138 [TBL] [Abstract][Full Text] [Related]
25. BRIP1 variations analysis reveals their relative importance as genetic susceptibility factor for cervical cancer. Ma XD; Cai GQ; Zou W; Huang YH; Zhang JR; Wang DT; Chen BL Biochem Biophys Res Commun; 2013 Apr; 433(2):232-6. PubMed ID: 23473757 [TBL] [Abstract][Full Text] [Related]
26. Screening for large genomic rearrangements of the BRIP1 and CHK1 genes in Finnish breast cancer families. Solyom S; Pylkäs K; Winqvist R Fam Cancer; 2010 Dec; 9(4):537-40. PubMed ID: 20567916 [TBL] [Abstract][Full Text] [Related]
27. Pathologic findings in breast, fallopian tube, and ovary specimens in non-BRCA hereditary breast and/or ovarian cancer syndromes: a study of 18 patients with deleterious germline mutations in RAD51C, BARD1, BRIP1, PALB2, MUTYH, or CHEK2. Schoolmeester JK; Moyer AM; Goodenberger ML; Keeney GL; Carter JM; Bakkum-Gamez JN Hum Pathol; 2017 Dec; 70():14-26. PubMed ID: 28709830 [TBL] [Abstract][Full Text] [Related]
28. The role of germline alterations in the DNA damage response genes BRIP1 and BRCA2 in melanoma susceptibility. Tuominen R; Engström PG; Helgadottir H; Eriksson H; Unneberg P; Kjellqvist S; Yang M; Lindén D; Edsgärd D; Hansson J; Höiom V Genes Chromosomes Cancer; 2016 Jul; 55(7):601-11. PubMed ID: 27074266 [TBL] [Abstract][Full Text] [Related]
29. Comprehensive Mutational Analysis of the BRCA1-Associated DNA Helicase and Tumor-Suppressor FANCJ/BACH1/BRIP1. Calvo JA; Fritchman B; Hernandez D; Persky NS; Johannessen CM; Piccioni F; Kelch BA; Cantor SB Mol Cancer Res; 2021 Jun; 19(6):1015-1025. PubMed ID: 33619228 [TBL] [Abstract][Full Text] [Related]
30. Rare germline mutations in African American men diagnosed with early-onset prostate cancer. Beebe-Dimmer JL; Zuhlke KA; Johnson AM; Liesman D; Cooney KA Prostate; 2018 Apr; 78(5):321-326. PubMed ID: 29356034 [TBL] [Abstract][Full Text] [Related]
32. Protein-truncating variants in moderate-risk breast cancer susceptibility genes: a meta-analysis of high-risk case-control screening studies. Aloraifi F; McCartan D; McDevitt T; Green AJ; Bracken A; Geraghty J Cancer Genet; 2015 Sep; 208(9):455-63. PubMed ID: 26250988 [TBL] [Abstract][Full Text] [Related]
33. BRIP1 (BACH1) variants and familial breast cancer risk: a case-control study. Frank B; Hemminki K; Meindl A; Wappenschmidt B; Sutter C; Kiechle M; Bugert P; Schmutzler RK; Bartram CR; Burwinkel B BMC Cancer; 2007 May; 7():83. PubMed ID: 17504528 [TBL] [Abstract][Full Text] [Related]
34. FANCJ/BRIP1 recruitment and regulation of FANCD2 in DNA damage responses. Zhang F; Fan Q; Ren K; Auerbach AD; Andreassen PR Chromosoma; 2010 Dec; 119(6):637-49. PubMed ID: 20676667 [TBL] [Abstract][Full Text] [Related]
35. Martín-Morales L; Garre P; Lorca V; Cazorla M; Llovet P; Bando I; García-Barberan V; González-Morales ML; Esteban-Jurado C; de la Hoya M; Castellví-Bel S; Caldés T Cancer Prev Res (Phila); 2021 Feb; 14(2):185-194. PubMed ID: 33115781 [TBL] [Abstract][Full Text] [Related]
36. A variant at a potentially functional microRNA-binding site in BRIP1 was associated with risk of squamous cell carcinoma of the head and neck. Liu H; Gao F; Dahlstrom KR; Li G; Sturgis EM; Zevallos JP; Wei Q; Liu Z Tumour Biol; 2016 Jun; 37(6):8057-66. PubMed ID: 26711789 [TBL] [Abstract][Full Text] [Related]
37. Common genetic variants associated with disease from genome-wide association studies are mutually exclusive in prostate cancer and rheumatoid arthritis. Orozco G; Goh CL; Al Olama AA; Benlloch-Garcia S; Govindasami K; Guy M; Muir KR; Giles GG; Severi G; Neal DE; Hamdy FC; Donovan JL; Kote-Jarai Z; Easton DF; Eyre S; Eeles RA BJU Int; 2013 Jun; 111(7):1148-55. PubMed ID: 22985493 [TBL] [Abstract][Full Text] [Related]
38. BRIP-1 germline mutation and its role in colon cancer: presentation of two case reports and review of literature. Ali M; Delozier CD; Chaudhary U BMC Med Genet; 2019 May; 20(1):75. PubMed ID: 31064327 [TBL] [Abstract][Full Text] [Related]
39. BRIP1, RAD51C, and RAD51D mutations are associated with high susceptibility to ovarian cancer: mutation prevalence and precise risk estimates based on a pooled analysis of ~30,000 cases. Suszynska M; Ratajska M; Kozlowski P J Ovarian Res; 2020 May; 13(1):50. PubMed ID: 32359370 [TBL] [Abstract][Full Text] [Related]
40. Landscape of BRIP1 molecular lesions in gastrointestinal cancers from published genomic studies. Voutsadakis IA World J Gastroenterol; 2020 Mar; 26(11):1197-1207. PubMed ID: 32231423 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]